Taken together, the CD11b+CD33+ MDSC level is correlated with the biochemical parameters of CLD patients, including the degree of liver fibrosis and enzymes related to liver injury, indicating that the level of MDSCs may be associated with disease progression. The gene discussed is ITGAM; the disease is Hepatic fibrosis.